Skip to main content
Figure 2 | Journal for ImmunoTherapy of Cancer

Figure 2

From: Response assessment in metastatic melanoma treated with ipilimumab and bevacizumab: CT tumor size and density as markers for response and outcome

Figure 2

Scatter plot of the percent changes of the tumor diameter and density on the first follow-up CT compared to the baseline CT in 21 patients. The cut-off values for response are indicated by the yellow dashed line for RECIST (≥30% diameter decrease), by the orange dashed line for MASS (≥20% diameter decrease), and by the purple dashed lines for Choi (≥10% diameter decrease or ≥15% density decrease) criteria. No patients met the density response criteria by MASS.

Back to article page